Get notified of page updates
Testing the Drug Obeticholic Acid for Familial Adenomatous Polyposis
Prevention study for people with an APC mutation and FAP or AFAP who have polyps in remaining tissue after colectomy surgery
Clinicaltrials.gov identifier:NCT05223036
Glossary on
off
This study is no longer enrolling patients.
This Study is Open To:
This study is no longer enrolling patients.
This Study is NOT Open To:
This study is no longer enrolling patients.
What the Study Involves
Participants will be divided into two groups:
- Group 1 will receive OCA for 6 months
- Group 2 will receive a for 6 months
All participants will undergo GI endoscopy with biopsy and collection of blood samples at screening and on study.
After completion of the study treatment, patients are followed within 14-21 days.
Prevention study for people with an APC mutation and FAP or AFAP who have polyps in remaining tissue after colectomy surgery
Clinicaltrials.gov identifier:NCT05223036